Nectar Lifesciences - Quaterly Results

14 Nov 2022 Evaluate
The September 2022 quarter revenue stood at Rs. 3886.47 millions, up 6.60% as compared to Rs. 3645.69 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2022 is Rs. -224.68 millions as compared to Net Profit of Rs. 18.62 millions of corresponding quarter ended September 2021The company reported a degrowth in operating Profit to 33.10 millions from 325.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 3886.47 3645.69 6.60 7916.70 7490.22 5.69 16682.56 15428.96 8.12
Other Income 107.10 50.97 110.12 110.74 102.43 8.11 112.93 27.22 314.88
PBIDT 33.10 325.55 -89.83 455.19 733.42 -37.94 1701.31 1129.49 50.63
Interest 209.88 180.09 16.54 423.54 437.54 -3.20 788.10 1120.32 -29.65
PBDT -176.78 145.46 -221.53 31.65 295.88 -89.30 913.21 -243.98 -474.30
Depreciation 147.91 141.54 4.50 294.86 284.32 3.71 569.68 602.53 -5.45
PBT -324.69 3.92 -8382.91 -263.21 11.56 -2376.90 343.53 -846.51 -140.58
TAX -100.01 -14.70 580.34 -77.89 -27.75 180.68 90.34 -115.04 -178.53
Deferred Tax -100.01 -14.70 580.34 -77.89 -27.75 180.68 90.34 -200.90 -144.97
PAT -224.68 18.62 -1306.66 -185.32 39.31 -571.43 253.19 -731.47 -134.61
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 0.74 7.75 -90.46 5.75 9.79 -41.28 8.84 6.41 37.98

Nectar Lifesciences Share Price

12.19 0.00 (0.00%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×